Cargando…

Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenib

The prognosis is usually poor in advanced hepatocellular carcinoma (HCC). Sorafenib is approved for Child-Pugh class A patients with unresectable and advanced HCC. We report here a rare case of a patient with advanced HCC with right portal vein thrombosis (PVT) who achieved a complete response after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kee, Kwong-Ming, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043808/ https://www.ncbi.nlm.nih.gov/pubmed/24920924 http://dx.doi.org/10.2147/OTT.S61740

Ejemplares similares

Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib
por: Kermiche-Rahali, Sabrina, et al.
Publicado: (2013)

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis
por: Que, Jenny, et al.
Publicado: (2020)

Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis
por: Jeong, Soung Won, et al.
Publicado: (2013)

Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Kim, Jina, et al.
Publicado: (2022)

Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies
por: Qi, Xingshun, et al.
Publicado: (2015)

Combination Intensity-Modulated Radiotherapy and Sorafenib Improves Outcomes in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Abulimiti, Munire, et al.
Publicado: (2021)

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
por: Lee, Jung Min, et al.
Publicado: (2016)

Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation
por: Chen, Hsin-Yeh, et al.
Publicado: (2020)

Early Experience of Oncolytic Virus Injection Combined with Sorafenib in a Patient with Advanced Hepatocellular Carcinoma and Portal Vein Thrombosis
por: Jo, Hyun Ho, et al.
Publicado: (2020)

Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Ahn, Young Eun, et al.
Publicado: (2021)

Portal vein thrombosis on unenhanced MRI: a case series
por: Lee, Chau Hung
Publicado: (2022)

Portal Vein Thrombosis
por: Cohen, Ronny, et al.
Publicado: (2015)

Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib
por: Kuo, Yuan-Hung, et al.
Publicado: (2022)

Sustained complete response of hepatocellular carcinoma with portal vein tumor thrombus following discontinuation of sorafenib: A case report
por: SHIOZAWA, KAZUE, et al.
Publicado: (2014)

Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
por: Nakazawa, Takahide, et al.
Publicado: (2014)

Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy
por: Kim, Pyeong Hwa, et al.
Publicado: (2019)

Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study
por: Cao, Yanyan, et al.
Publicado: (2021)

Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Deng, Min, et al.
Publicado: (2023)

The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy
por: Bae, Bong Kyung, et al.
Publicado: (2016)

New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
por: Woo, Hyun Young, et al.
Publicado: (2015)

Folate levels in hepatocellular carcinoma patients with portal vein thrombosis
por: Malaguarnera, Giulia, et al.
Publicado: (2020)

Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides
por: Khan, Abdul Rehman, et al.
Publicado: (2021)

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Zane, Kylie E., et al.
Publicado: (2021)

Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis
por: Kim, Sang Jin, et al.
Publicado: (2021)

TIPS performed in a patient with complete portal vein thrombosis
por: Sharma, Ashwani Kumar, et al.
Publicado: (2017)

Complete spontaneous necrosis of hepatocellular carcinoma accompanied by portal vein tumor thrombosis: A case report
por: Goto, Yuichi, et al.
Publicado: (2018)

Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply
por: Yim, Hyung Joon, et al.
Publicado: (2023)

Melioidosis with Portal Vein Thrombosis
por: Direksunthorn, Thanyaporn
Publicado: (2017)

Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib
por: Liu, Daizhong, et al.
Publicado: (2015)

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
por: Lv, Wei-Fu, et al.
Publicado: (2018)

Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis
por: Lee, Wei-Chen, et al.
Publicado: (2017)

Non-Traumatic Intramuscular Hip Hematoma in a Cirrhotic Patient With Hepatocellular Carcinoma and Portal Vein Thrombosis Treated With Sorafenib and Low Molecular Weight Heparin
por: Sotiropoulos, Christos, et al.
Publicado: (2021)

Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data
por: Yen, Yi-Hao, et al.
Publicado: (2019)

Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case
por: Wang, Ming-Hung, et al.
Publicado: (2021)

Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation
por: Hung, Hao-Chien, et al.
Publicado: (2020)

Spontaneous Resolution of Portal Vein Thrombosis
por: Banumukala, Vishnu, et al.
Publicado: (2008)

Etiology and Complications of Portal Vein Thrombosis
por: Trebicka, Jonel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h529hvbanboji1nl2ugrea422l